Cargando…

Host-targeting oral antiviral drugs to prevent pandemics

Detalles Bibliográficos
Autores principales:	Dwek, Raymond A, Bell, John I, Feldmann, Marc, Zitzmann, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956295/ https://www.ncbi.nlm.nih.gov/pubmed/35344736 http://dx.doi.org/10.1016/S0140-6736(22)00454-8

Ejemplares similares

Iminosugar antivirals: the therapeutic sweet spot
por: Alonzi, Dominic S., et al.
Publicado: (2017)

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19
por: Migaud, Marie, et al.
Publicado: (2020)

Modelling the evolution of drug resistance in the presence of antiviral drugs
por: Wu, Jianhong, et al.
Publicado: (2007)

Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus
por: Branza-Nichita, Norica, et al.
Publicado: (2002)

Glucocorticosteroids as Dengue Therapeutics: Resolving Clinical Observations With a Primary Human Macrophage Model
por: Sayce, Andrew C., et al.
Publicado: (2013)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

Monkeypox treatment options: current status of antiviral drugs – a correspondence
por: Ganapthy, Dhanraj, et al.
Publicado: (2023)

Running interference on miR-33: a new amplification loop for type I interferon in the host antiviral response
por: Zhao, Fei, et al.
Publicado: (2020)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target
por: Sobala, Łukasz F., et al.
Publicado: (2020)

In reply: Withholding therapeutic interventions in brain(stem) death: is it a self-fulfilling prophecy?
por: Walter, Uwe, et al.
Publicado: (2022)

Antiviral effects of oleandrin
por: Newman, R., et al.
Publicado: (2021)

Matching target dose to target organ
por: Bannon, Desmond I., et al.
Publicado: (2017)

Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus
por: Miller, Joanna L., et al.
Publicado: (2018)

COVID-19 therapeutics: Challenges and directions for the future
por: Robinson, Philip C., et al.
Publicado: (2022)

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
por: Takashita, Emi, et al.
Publicado: (2022)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

One Health or Planetary Health for pandemic prevention?
por: Waugh, Courtney, et al.
Publicado: (2020)

Rationale of receptor-based antivirals against SARS
Publicado: (2013)

Early triple antiviral therapy for COVID-19
por: Lee, Nelson, et al.
Publicado: (2020)

Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021)

The preventive strategies of COVID-19 pandemic in Saudi Arabia
por: Nurunnabi, Mohammad
Publicado: (2021)

Removal of beneficial insertion effects prevent the long-term persistence of transposable elements within simulated asexual populations
por: Butler, Christopher L., et al.
Publicado: (2021)

Advances in targeted drugs for allergic diseases
por: Wang, Xue-Song, et al.
Publicado: (2021)

New Approaches for Biomarker Discovery: The Search for Liver Fibrosis Markers in Hepatitis C Patients
por: Gangadharan, Bevin, et al.
Publicado: (2011)

The way forward for drug-resistant tuberculosis in the Philippines
por: Bernardo, Madeleine Nicole G, et al.
Publicado: (2022)

Functional exhaustion of antiviral lymphocytes in COVID-19 patients
por: Zheng, Meijuan, et al.
Publicado: (2020)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

The host interactome of influenza virus presents new potential targets for antiviral drugs
por: Shaw, Megan L.
Publicado: (2011)

Oral lesions and monkeypox: increasing the need for prevention and access of a novel zoonotic disease – correspondence
por: Yasasve, Madhavan, et al.
Publicado: (2023)

Antivirals for the treatment and prevention of epidemic and pandemic influenza
por: Oxford, John S.
Publicado: (2007)

Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
por: Loureiro, L. R., et al.
Publicado: (2018)

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus
por: Jasenosky, Luke D., et al.
Publicado: (2019)

The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
por: Fan, Huahao, et al.
Publicado: (2022)

Virus–host interactomes — antiviral drug discovery
por: Ma-Lauer, Yue, et al.
Publicado: (2012)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023)

WHO Living Guidelines on antivirals for COVID-19 are evidence-based
por: Owen, Andrew, et al.
Publicado: (2023)

Advances in graft-versus-host disease prevention strategies: latest updates from the 2022 ASH annual meeting
por: Chen, Yiyin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q1l571r3jo3gsmb77edll5u82o